Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 693,200 | 653,000 | 651,600 | 585,400 | 667,500 |
| Cost of Goods | 348,000 | 309,600 | 306,300 | 279,400 | 325,500 |
| Gross Profit | 345,200 | 343,400 | 345,300 | 306,000 | 342,000 |
| Operating Expenses | 464,100 | 278,700 | 268,500 | 282,700 | 284,100 |
| Operating Income | -118,900 | 65,300 | 77,100 | 23,700 | 58,400 |
| Interest Expense | 12,100 | 12,300 | 12,600 | 12,000 | 12,200 |
| Other Income | 1,060,200 | -484,100 | 349,500 | 71,700 | -955,100 |
| Pre-tax Income | 929,200 | -431,100 | 414,000 | 83,400 | -908,900 |
| Income Tax | 209,200 | -89,200 | 96,200 | 19,400 | -193,100 |
| Net Income Continuous | 720,000 | -341,900 | 317,800 | 64,000 | -715,800 |
| Net Income | $720,000 | $-341,900 | $317,800 | $64,000 | $-715,800 |
| EPS Basic Total Ops | 26.61 | -12.70 | 11.67 | 2.29 | -25.93 |
| EPS Basic Continuous Ops | 26.61 | -12.70 | 11.67 | 2.29 | -25.93 |
| EPS Diluted Total Ops | 26.59 | -12.70 | 11.67 | 2.29 | -25.89 |
| EPS Diluted Continuous Ops | 26.59 | -12.70 | 11.67 | 2.29 | -25.90 |
| EPS Diluted Before Non-Recurring Items | 2.51 | 2.26 | 2.61 | 2.54 | 2.90 |
| EBITDA(a) | $-118,900 | $65,300 | $77,100 | $23,700 | $58,400 |